QTRX(Quanterix Corporation) · 财务报表

QTRX(Quanterix Corporation) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$110.56M$105.52M$122.37M$137.42M$138.90M
毛利润$64.77M$45.36M$74.22M$83.10M$64.96M
营业利润−$56.52M−$104.26M−$45.99M−$52.62M−$125.54M
净利润−$55.55M−$99.57M−$28.35M−$38.53M−$107.15M
经营现金流−$47.62M−$48.61M−$18.85M−$35.16M−$77.24M
自由现金流−$61.30M−$60.23M−$22.69M−$38.53M−$79.85M
摊薄每股收益$-1.54$-2.69$-0.75$-1.00$-2.51

Quanterix Corporation QTRX